Washington D.C., Aug 9, 2018 / 06:30 am
Legislators, pro-life groups, and ethicists have condemned a new government contract to obtain human tissue from aborted children for use in medical research and in the creation of “humanized mice.”
The Food and Drug Administration signed a $15,900 contract to acquire human fetal tissue for use on mice on July 25. The contract was signed with Advanced Bioscience Resources Inc., a California based not-for-profit. It is the eighth contract between the FDA and ABR since 2012, seven of the contracts appear to relate to the same or similar programs.
The fetal tissue used in such research is obtained from elective abortions, according to a report from the Congressional Research Service.
The fetal tissue the FDA intends to purchase would be injected into mice with compromised immune systems in order to create a “chimeric animal” with an immune system like that of a human being.
ABR was mentioned in a series of videos secretly filmed by the Center for Medical Progress, released in 2015, accusing Planned Parenthood of profiting from the sale of fetal tissue obtained through abortions. At that time, Politico reported that, in one video, a former medical director for Planned Parenthood said that the abortion provider had been “using ABR for over 10 years – a really long time.”
Pro-life groups have condemned the contract. The Center for Medical Progress (CMP) released a statement calling the deal “unconscionable” and said that contracts with organizations like ABR makes the FDA “directly complicit in these abortions.” CMP suggested that the contracts imply that unborn children are “worth more to the U.S. Government dead than alive.”
There are numerous ethical concerns, not only with the purchase of aborted fetuses but with a lack of respect for their dignity, a Catholic ethicist told CNA.
“The FDA contract with Advance Bioscience Resources appears to be problematic on a number of different levels,” Dr. Jozef Zalot, staff ethicist at the National Catholic Bioethics Center said Aug. 8.